NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q39693506
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor ActivityCD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytesNatural killer cells in human cancer: from biological functions to clinical applicationsExpansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma.Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.Natural killer cells in patients with severe chronic fatigue syndrome.CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancerPhenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15.Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma.Human CD56bright NK Cells: An Update.Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of LiteratureIncreased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers.Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer.Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.PD-L1 blockade enhances anti-tumor efficacy of NK cells
P2860

NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma.

Item
http://www.wikidata.org/entity/Q39693506
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@en
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@nl
type
label
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@en
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@nl
prefLabel
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@en
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
NK cell dysfunction with down- ...... ageal squamous cell carcinoma.
@en
P2093
P304
P31
P356
10.1111/J.1442-2050.2010.01073.X
P433
P478
P577
P698